activins has been researched along with Disease Exacerbation in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (24.32) | 29.6817 |
2010's | 23 (62.16) | 24.3611 |
2020's | 5 (13.51) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Han, L; Wu, H; Xie, T | 1 |
Bostantzoglou, C; Fari, O; Gaga, M; Morianos, I; Photiades, A; Potaris, K; Semitekolou, M; Tsitsopoulou, A; Valakos, D; Vatsellas, G; Xanthou, G | 1 |
Ankersmit, HJ; Bekos, C; Dome, B; Hacker, P; Janik, S; Klepetko, W; Moser, B; Müllauer, L; Raunegger, T; Schiefer, AI; Veraar, C | 1 |
Bachy, S; Bernard, D; Bertolino, P; Chanal, M; Collin, G; Flaman, JM; Goehrig, D; Guillaumond, F; Hennino, A; Pasternack, A; Principe, M; Ritvos, O; Tomasini, R; Vasseur, S; Wu, Z; Zhao, Y; Ziverec, A | 1 |
Borkowska, A; Malecka-Panas, E; Olakowski, M; Talar-Wojnarowska, R; Wozniak, M | 1 |
Chen, J; Chen, Y; Ding, Z; Dong, L; Huang, Z; Kang, Z; Qian, B; Sun, X; Zang, Y; Zhang, J | 1 |
Bhushan, S; Chen, JL; de Kretser, DM; Fijak, M; Gregorevic, P; Hayward, S; Hedger, MP; Loveland, KL; Meinhardt, A; Muir, JA; Nicolas, N; Stanton, PG | 1 |
Constam, DB; Donovan, P; Dubey, OA; Kallioinen, S; Muehlethaler, K; Müller, P; Rimoldi, D; Rogers, KW | 1 |
Morris, GP; Rentsch, P; Stayte, S; Vissel, B | 1 |
Ott, SM | 1 |
Kamijo, H; Miyagaki, T; Nakajima, R; Oka, T; Sato, S; Senda, N; Shishido-Takahashi, N; Suga, H; Sugaya, M | 1 |
Adland, E; Goulder, PJR; Groll, A; Kløverpris, H; Leslie, A; Moore, PL; Morris, L; Muenchhoff, M; Ndung'u, T; Ogongo, P; Porterfield, JZ; Roider, J | 1 |
Aakhus, S; Aukrust, P; Birkeland, KI; Endresen, K; Fagerland, MW; Gullestad, L; Johansen, OE; Ofstad, AP; Orvik, E; Ueland, T | 1 |
de Velasco, MA; Fujita, Y; Hayashi, H; Kitano, M; Kogita, A; Kudo, M; Nishio, K; Okuno, K; Sakai, K; Sakamoto, H; Terashima, M; Togashi, Y; Tomida, S | 1 |
Castelli, G; Elvira, P; Testa, U | 1 |
Lin, HY; Nana, AW; Yang, PM | 1 |
Breuning, MH; De Heer, E; El Bouazzaoui, F; Hoogaars, WM; Jianu, SB; Kunnen, SJ; Leonhard, WN; Pasternack, A; Peters, DJ; Plugge, AJ; Ritvos, O; Ten Dijke, P; Veraar, K | 1 |
Buzelin, MA; Couto, HL; Dela Cruz, C; Reis, FM; Toppa, NH; Wainstein, AJ | 1 |
Ancona, C; Badalamenti, G; Crescimanno, M; Flandina, C; Fulfaro, F; Incorvaia, L; Leto, G; Sepporta, MV | 1 |
Kang, SO; Liu, R; Sun, B; Wang, JH; Xu, C | 1 |
Ahmad, J; El-Shemi, AG; Idris, S; Kensara, OA; Mohamed, AM; Refaat, B | 1 |
Hiromura, K; Ikeuchi, H; Kadiombo, AT; Kaneko, Y; Kayakabe, K; Maeshima, A; Nojima, Y; Sakairi, T | 1 |
Brimioulle, S; Dewachter, L; Hadad, I; Jespers, P; Mahmoudabady, M; Mathieu, M; McEntee, K; Naeije, R; Ray, L | 1 |
Chang, KP; Chang, YL; Cheng, MH; Hao, SP; Kao, HK; Ko, TY; Lee, YS; Liang, Y; Lin, YC; Liu, SC; Tsai, CL; Tsai, CN; Wang, TH | 1 |
Peng, C; Wang, X; Xu, G; Yang, C; Zeng, F; Zhou, H; Zhou, T | 1 |
Gold, E; Ottley, E | 1 |
Caja, L; Kahata, K; Moustakas, A | 1 |
de Jong, FH; Dits, NF; Hofland, J; Jenster, G; Steenbergen, J; van Weerden, WM | 1 |
Gold, E; Harrison, C; Makanji, Y; Marino, FE; Risbridger, G | 1 |
Bläuer, M; Puistola, U; Tuohimaa, P; Vihko, KK | 1 |
Brück, W; Bunkowski, S; E O'Connor, A; Gerber, J; Michel, U; Nau, R; Phillips, DJ | 1 |
Lin, SL; Ying, SY | 1 |
Foster, JA; Herkenham, M; McIntyre, DC; Puchowicz, MJ | 1 |
Borawski, J; Myśliwiec, M | 1 |
Kumar, R; Li, Q; Loveland, KL; Matzuk, MM; O'Connor, AE; Seehra, JS; Underwood, K | 1 |
Chen, L; Cipriano, SC; Kumar, TR; Matzuk, MM | 1 |
Hirschberg, R; Lapage, J; Wang, SN | 1 |
5 review(s) available for activins and Disease Exacerbation
Article | Year |
---|---|
Renal insufficiency and bone loss.
Topics: Activins; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Progression; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Renal Insufficiency, Chronic; Wnt Proteins | 2019 |
Experimental and investigational therapies for chemotherapy-induced anemia.
Topics: Activins; Anemia; Animals; Antineoplastic Agents; Disease Progression; Drug Design; Drugs, Investigational; Hematinics; Hepcidins; Humans; Neoplasms | 2015 |
Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Topics: Activins; Animals; Bone Morphogenetic Proteins; Brain Neoplasms; Disease Progression; Epithelial-Mesenchymal Transition; Glioblastoma; Humans; Immunomodulation; Left-Right Determination Factors; Neoplasm Invasiveness; Neovascularization, Pathologic; Nodal Protein; Signal Transduction; Transforming Growth Factor beta | 2015 |
Insensitivity to the growth inhibitory effects of activin A: an acquired capability in prostate cancer progression.
Topics: Activins; Cell Proliferation; Cell Transformation, Neoplastic; Disease Progression; Growth Inhibitors; Humans; Male; MicroRNAs; Prostatic Neoplasms | 2012 |
Context-dependent action of transforming growth factor β family members on normal and cancer stem cells.
Topics: Activins; Adult; Adult Stem Cells; Animals; Antineoplastic Agents; Bone Morphogenetic Proteins; Disease Progression; Drug Resistance, Neoplasm; Embryonic Stem Cells; Humans; Neoplasms; Neoplastic Stem Cells; Signal Transduction; Transforming Growth Factor beta | 2012 |
32 other study(ies) available for activins and Disease Exacerbation
Article | Year |
---|---|
Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Topics: Activins; Disease Progression; Humans; Idiopathic Pulmonary Fibrosis; Pilot Projects; Prognosis; Progranulins | 2021 |
Activin-A impedes the establishment of CD4
Topics: Activins; Adoptive Transfer; Animals; Biomarkers; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Disease Progression; Disease Susceptibility; Gene Expression Regulation, Neoplastic; HMGB Proteins; Humans; Immunity, Cellular; Immunophenotyping; Lung Neoplasms; Lymphocyte Count; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Transgenic; Signal Transduction | 2021 |
Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors.
Topics: Activins; Adult; Aged; Case-Control Studies; Disease Progression; Female; Follistatin; Humans; Male; Middle Aged; Myasthenia Gravis; Neoplasms, Glandular and Epithelial; Neovascularization, Pathologic; Postoperative Period; Prognosis; Thymus Gland; Thymus Neoplasms | 2019 |
Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Animals; Carcinoma, Pancreatic Ductal; Cellular Senescence; Disease Progression; Genes, ras; Humans; Mice; Pancreatic Neoplasms; Phosphorylation; Precancerous Conditions; Proto-Oncogene Proteins p21(ras); Transcriptional Activation | 2020 |
Clinical significance of activin A and myostatin in patients with pancreatic adenocarcinoma and progressive weight loss.
Topics: Activins; Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Humans; Male; Middle Aged; Myostatin; Pancreatic Neoplasms; Prospective Studies; Weight Loss | 2020 |
Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma.
Topics: Activins; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibin-beta Subunits; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Paracrine Communication; Signal Transduction; Smad Proteins; SOX9 Transcription Factor; Tumor Microenvironment; Up-Regulation; Xenograft Model Antitumor Assays | 2021 |
Induction of experimental autoimmune orchitis in mice: responses to elevated circulating levels of the activin-binding protein, follistatin.
Topics: Activins; Animals; Apoptosis; Autoimmune Diseases; Biomarkers; Blood-Testis Barrier; Disease Models, Animal; Disease Progression; Fibrosis; Follistatin; Gene Expression Regulation; Gene Transfer Techniques; Inflammation Mediators; Male; Mice, Inbred C57BL; Orchitis; Recombinant Proteins; Testis; Up-Regulation | 2017 |
Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion.
Topics: Activins; Animals; Cachexia; Cell Cycle; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immune Evasion; Immune System; Ki-67 Antigen; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Phenotype; Signal Transduction; Skin Neoplasms; Tumor Microenvironment | 2017 |
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia.
Topics: Activins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Disease Progression; Dyskinesia, Drug-Induced; Levodopa; Male; Medial Forebrain Bundle; Mice, Inbred C57BL; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Random Allocation; Treatment Failure | 2019 |
Increased Serum Activin A Levels in Mycosis Fungoides and Sézary Syndrome.
Topics: Activins; Aged; Case-Control Studies; Disease Progression; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Sezary Syndrome; Skin Neoplasms; Up-Regulation | 2019 |
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
Topics: Activins; Adolescent; Biomarkers; Broadly Neutralizing Antibodies; Chemokine CXCL13; Child; Cohort Studies; Disease Progression; Germinal Center; HIV Antibodies; HIV Infections; HIV-1; Humans; Interleukin-5; Neutralization Tests; T-Lymphocytes, Helper-Inducer; Viral Load | 2019 |
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.
Topics: Activins; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Diabetes Mellitus, Type 2; Disease Progression; Echocardiography, Stress; Electrocardiography; Female; Hospitalization; Humans; Interleukin-6; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2013 |
Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.
Topics: Activins; Aged; Aged, 80 and over; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cachexia; Cell Proliferation; Disease Progression; Female; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Survival Rate; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2015 |
Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease.
Topics: Activins; Animals; Disease Progression; Epithelial Cells; Female; Kidney; Male; Mice; Polycystic Kidney Diseases; Recombinant Fusion Proteins; Signal Transduction; Smad2 Protein; Smad3 Protein; Time Factors | 2016 |
Follistatin Expression in Human Invasive Breast Tumors: Pathologic and Clinical Associations.
Topics: Activins; Breast Neoplasms; Carcinogenesis; Cell Cycle; Cell Proliferation; Disease Progression; Estrogen Receptor alpha; Female; Follistatin; Follow-Up Studies; Humans; Immunohistochemistry; Mammary Glands, Human; Menopause; Neoplasm Metastasis; Neoplasm Staging; Paraffin Embedding; Receptor, ErbB-2 | 2018 |
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report.
Topics: Activins; Aged; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Cathepsin L; Cystatin C; Disease Progression; Female; Follistatin; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Osteoporosis; ROC Curve | 2016 |
Activin pathway enhances colorectal cancer stem cell self-renew and tumor progression.
Topics: Activin Receptors; Activins; Benzamides; Cell Self Renewal; Colorectal Neoplasms; Dioxoles; Disease Progression; HCT116 Cells; Humans; Metabolic Networks and Pathways; Molecular Targeted Therapy; Neoplastic Stem Cells | 2016 |
Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer.
Topics: Activins; Adenocarcinoma; Animals; Azoxymethane; Biomarkers, Tumor; Carcinogenesis; Colonic Neoplasms; Disease Progression; Follistatin; Gene Expression; Male; Precancerous Conditions; Rats, Wistar | 2016 |
Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
Topics: Activins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Disease Progression; Female; Fibrosis; Follistatin; Kidney; Lupus Nephritis; Macrophages; Mice; Mice, Inbred MRL lpr; Proteinuria | 2017 |
Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy.
Topics: Activins; Animals; Cardiomyopathy, Dilated; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cytokines; Disease Progression; Dogs; Gene Expression; Intercellular Signaling Peptides and Proteins; Models, Animal; Myostatin; Signal Transduction; Ultrasonography | 2008 |
Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
Topics: Activins; Adult; Aged; Blotting, Western; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follistatin; Humans; Immunoenzyme Techniques; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survival Rate; Tumor Cells, Cultured | 2010 |
Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression.
Topics: Activin Receptors, Type I; Activins; Adult; Aged; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Lymphatic Metastasis; Middle Aged; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta | 2012 |
Activin A stimulates AKR1C3 expression and growth in human prostate cancer.
Topics: 3-Hydroxysteroid Dehydrogenases; Activins; Aldo-Keto Reductase Family 1 Member C3; Androgens; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Prostatic Neoplasms; Signal Transduction; Testosterone | 2012 |
Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Topics: Activins; Animals; Apoptosis; Cachexia; Cell Line; Cell Proliferation; Dimerization; Disease Progression; Female; Follistatin; Gene Expression; Humans; Inhibin-beta Subunits; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovarian Neoplasms; Phosphorylation; Sequence Deletion; Smad2 Protein; Testicular Neoplasms | 2013 |
Activin B in patients with granulosa cell tumors: serum levels in comparison to inhibin.
Topics: Activins; Adolescent; Biological Assay; Disease Progression; Female; Granulosa Cell Tumor; Humans; Inhibins; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms | 2003 |
Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia.
Topics: Activins; Animals; Anti-Bacterial Agents; Apoptosis; Brain; Cerebrospinal Fluid; Disease Models, Animal; Disease Progression; Hippocampus; Immunohistochemistry; Meningitis, Pneumococcal; Microglia; Neurons; Rabbits; Up-Regulation | 2003 |
Gene expression in precursor cells of prostate cancer associated with activin by combination of subtractive hybridization and microarray technologies.
Topics: Activins; Blotting, Northern; Cell Line, Tumor; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Staging; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; RNA, Neoplasm | 2004 |
Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures.
Topics: Activins; Amygdala; Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Disease Models, Animal; Disease Progression; Epilepsy, Temporal Lobe; Functional Laterality; Glutamate Decarboxylase; Isoenzymes; Kindling, Neurologic; Neurons; Rats; Rats, Long-Evans; Reaction Time; RNA, Messenger; Seizures; Time Factors; Transcriptional Activation; Up-Regulation | 2004 |
[Relevance of some growth factors to cardiovascular disease in maintenance hemodialysis patients].
Topics: Activins; Biomarkers; Cardiovascular Diseases; Disease Progression; Follistatin; Heparin; Hepatocyte Growth Factor; Humans; Kidney Failure, Chronic; Renal Dialysis | 2006 |
Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Topics: Activin Receptors, Type II; Activins; Animals; Cachexia; Disease Progression; Female; Follicle Stimulating Hormone; Gastric Mucosa; Immunoglobulin Fc Fragments; Immunoglobulin G; Inhibins; Liver; Male; Mice; Mice, Knockout; Recombinant Fusion Proteins; Sex Cord-Gonadal Stromal Tumors; Stomach; Syndrome; Testicular Neoplasms; Wasting Syndrome | 2007 |
Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Topics: Activins; Animals; Disease Progression; Female; Follistatin; Glycoproteins; Inhibins; Liver Diseases; Male; Metallothionein; Mice; Mice, Transgenic; Ovarian Neoplasms; Peptides; Stomach Diseases; Survival Analysis; Testicular Neoplasms; Wasting Syndrome | 2000 |
Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy.
Topics: Activins; Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Cells, Cultured; Cytokines; Diabetic Nephropathies; Disease Progression; Down-Regulation; Follistatin; Intercellular Signaling Peptides and Proteins; Kidney Tubules, Proximal; Mice; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Recombinant Proteins; Reference Values; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta | 2001 |